In a nutshell This study analyzed the rates of disease upgrading after biopsy (tissue sample) tests in men with low-risk prostate cancer. Researchers concluded that men with low-risk prostate cancer have a very low risk of being upgraded during active surveillance. Some background Most men diagnosed with prostate cancer are categorized as low...
Read MoreIn a nutshell The main aim of this study was to assess urinary tract symptoms (LUTS) in prostate cancer patients following robotic-assisted laparoscopic prostatectomy (RALP). The authors concluded that the majority of patients with moderate to severe LUTS improved significantly following RALP. Some background RALP is a relatively new...
Read MoreIn a nutshell The main objective of this review was to summarize evidence on the effect of lifestyle and diet on prostate cancer progression, recurrence and death. The authors concluded that a variety of factors appeared to affect prostate cancer progression, including not smoking, exercise and healthy body weight. Some background Prostate...
Read More
In a nutshell This study examined the effect of a supervised exercise and diet program on markers of heart disease risk in men undergoing androgen deprivation therapy (ADT). Researchers report preliminary evidence that lifestyle changes can improve fitness and arterial function in men undergoing long-term ADT. Some background ADT is a common...
Read More
What are the common side effects of advanced prostate cancer treatment, and how can they be managed? An expert panel—including Dr. Jeri Kim, Dr. Sumit Subudhi and Zita Dubauskas Lim—shares an overview of side effects associated with hormonal therapies, chemotherapy and immunotherapy. Published By : Patient Power Date : Aug 18,...
Read More
Hormonal therapy—also known as androgen deprivation therapy—has long been used to treat prostate cancer. But how does it work? And what are the potential side effects? Prostate cancer experts Drs. Jeri Kim and Sumit K. Subudhi, from MD Anderson Cancer Center, explore approved hormonal therapy...
Read More
In a nutshell The main objective of this study was to review all data available on focal radiotherapy (FRT) for men with early prostate cancer. The authors concluded that FRT was an option in early prostate cancer but may not be as effective in intermediate-risk tumors. Some background Radiation therapy is an important part of prostate cancer...
Read More
In a nutshell This review summarized evidence on emerging immunotherapies for prostate cancer. Authors concluded that immunotherapeutic agents show promising early results in patients with advanced prostate cancer and few symptoms. Some background Immunotherapies are currently under investigation as possible cancer treatments. Immunotherapies...
Read More
In a nutshell This study examined predictors of survival for cancer patients with spinal bone metastases. Authors reported that stable and unstable spinal bone metastases had similar survival rates. However, factors predictive of survival were different between groups. Some background When cancer spreads outside of the prostate (known as...
Read More
In a nutshell This study examined two new predictors of prostate cancer recurrence – perineural invasion (PNI) and lymphovascular invasion (LVI). Researchers reported increased recurrence risk after prostate surgery if patients show PNI or LVI before surgery, particularly if both were present. Some background Localized (confined)...
Read More
In a nutshell This study examined the effect of ethnicity on health outcomes with androgen deprivation therapy (ADT). Researchers reported shorter survival among African American men receiving ADT for low- or intermediate-risk prostate cancer compared to men of other ethnicities. Some background ADT is a type of hormone therapy used to treat...
Read More
In a nutshell This study examined health outcomes based on PSA (prostate specific antigen) levels in men with high-grade disease. Authors reported more aggressive cancers with low PSA compared to medium PSA. Low PSA appeared to progress similarly to high PSA in men with high-grade disease. Some background Prostate cancer is often graded based on...
Read More
